VYNE Therapeutics
VYNE
#9889
Rank
A$39.24 M
Marketcap
$2.58
Share price
-6.59%
Change (1 day)
-40.00%
Change (1 year)

EPS for VYNE Therapeutics (VYNE)

EPS in 2023 (TTM): -$16.57

According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -$18.26. In 2022 the company made an earnings per share (EPS) of -$12.12 an increase over its 2021 EPS that were of -$42.87.

EPS history for VYNE Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$16.5736.7%
2022-$12.12-71.72%
2021-$42.87-84.19%
2020-$271.22-26.29%
2019-$367.9828.75%
2018-$285.8110.79%
2017-$257.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.61-80.25%๐Ÿ‡บ๐Ÿ‡ธ USA